Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CE mark for Angeion's AngePass Lead System:

This article was originally published in Clinica

Executive Summary

Angeion has CE-marked its AngePass lead system which comprises both 4040 and 4080 models in the AngePass series. It is designed to lower energy thresholds required to convert critical cardiac arrhythmias to normal rhythm and intended for use with the company's Small Cap and Tuned biphasic waveform. The 4040 offers a tined passive fixation tip and is placed in the apex of the right ventricle. Alternatively, it could be augmented with the 4080 which is placed in the superior vena cava.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT086788

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel